Management of antiphospholipid syndrome during pregnancy.
Esplin
M S
MS
University of Utah Health Sciences Center, Salt Lake City, Utah, USA. mesplin@hsc.utah.edu
D000022:Abortion, Spontaneous / Q000209:etiology / Q000517:prevention & control; D000925:Anticoagulants / Q000627:therapeutic use; D016736:Antiphospholipid Syndrome / Q000145:classification / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D003376:Counseling; D005260:Female; D005313:Fetal Death / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D009774:Obstetrics / Q000379:methods*; D010927:Placental Insufficiency / Q000209:etiology / Q000517:prevention & control; D016742:Preconception Care / Q000379:methods; D011247:Pregnancy; D011248:Pregnancy Complications / Q000145:classification / Q000175:diagnosis / Q000628:therapy*; D011256:Pregnancy Outcome; D011295:Prenatal Care / Q000379:methods*; D012307:Risk Factors; D013927:Thrombosis / Q000209:etiology / Q000517:prevention & control
D000925:Anticoagulants